Cytel scientist Dr. Yannis Jemiai discusses important statistical considerations critical for clinical trial success. Communication at all levels of the drug development pipeline improves the chances of success, but many sponsors without in-depth statistical experience struggle to understand the nuances of statistical details. Dr. Jemiai introduces Solara, a clinical trial tool that helps to visualize and convey data in a straightforward manner.
Dr. Jemiai notes, “The complexity of clinical trial optimization comes from the need to align priorities on the one hand, and to understand opportunities on the other. We know that at a very general level, clinical operations specialists benefit from simplicity in clinical trial design, and that commercial teams prefer shorter clinical trials to longer ones. We also know that the statistical design of a clinical trial can influence both simplicity and duration. Yet how many sponsors have their clinical operations and commercial teams, sit with their R&D teams to review various statistically nuanced design options?” Read more here.
(Source: Cytel, 4/20/2021)